Clinical Trial Update: Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study of perampanel as an adjunctive treatment for inadequately controlled seizures in Lennox-Gastaut syndrome was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Lennox-Gastaut Syndrome (LGS) | Phase 3 | Status: TERMINATED | Results posted: 2022-03-09